21:03 , Jan 27, 2017 |  BC Week In Review  |  Financial News

Applied BioCode financial update

Diagnostic company Applied BioCode Inc. (Santa Fe Springs, Calif.) began the formal process to list on the Taipei Exchange in Taiwan by applying as an emerging stock on the exchange. The company expects to begin...
08:00 , Mar 3, 2014 |  BC Week In Review  |  Clinical News

GA-map IBS Dysbiosis Test regulatory update

Genetic Analysis said its GA-map IBS Dysbiosis Test received CE Mark approval to analyze dysbiosis (imbalances in gut microbiota) in patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). The test utilizes common...
07:00 , Apr 25, 2011 |  BC Week In Review  |  Company News

Applied BioCode, EraGen sales and marketing update

EraGen received non-exclusive, worldwide rights to commercialize Applied BioCode's Barcoded Magnetic Bead technology and BioCode-1000 system for infectious disease and genetic diagnostic tests. The Barcoded Magnetic Bead technology is used to improve the isolation and...
07:00 , May 5, 1997 |  BioCentury  |  Finance

Oxford's new fund

Oxford Bioscience Partners closed its second fund last week - Oxford Bioscience Partners II - an $81.5 million fund that will continue the firm's focus in the biotechnology and health science sectors. A key difference...